Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Product Launch

24 Oct 2007 07:00

Concurrent Technologies Plc Product Launch Conduction-cooled rugged computer board

Concurrent Technologies Plc (the "Company"), a world leading specialist in the design and manufacture of high-end embedded computer products, announces the launch of its latest single board computer, the TP 402/351-RC, specially designed for use in rugged environments.

This 3U CompactPCI‚® board uses the latest dual-core processors from Intel‚® and is conduction-cooled for use in very harsh operating environments. As such, it is well suited for applications within the defence, aerospace, security, transportation, industrial-control and telemetry sectors. In addition, this product is available as a ruggedized air-cooled version as well as in an extended temperature range version. The product is also capable of operating at high altitudes and can sustain very high shock and vibration levels.

Part of the Company's strategy has been to design and produce these types of rugged computer products. The launch of this board is the first product resulting from this strategy and as such, it clearly demonstrates that the Company has the skills and expertise to design and produce extremely sophisticated products using the latest processing technology.

Glen Fawcett, Managing Director, commented:

"Designing and manufacturing computer products for use in extremely demanding applications is a highly specialised field and one in which we now clearly have wide ranging skills. A principle management aim is to capture the widest possible audience for our products. The type of technological innovation that has been applied in this product demonstrates that our aims are being fulfilled."

24 October 2007Contacts:Concurrent Technologies Plc 01206 752 626 Glen Fawcett, Managing Director Nexus Financial Ltd 020 7451 7050 Nicholas Nelson/Kathy Boate Nominated Adviser Brewin Dolphin 0845 213 1120 Alan Stewart

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

Notes to Editors:

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in the telecommunications, defence, security, telemetry, scientific and aerospace markets. Using the latest Intel‚® Core¢â€ž¢ dual core processors, the single board computers support high performance applications, some being capable of operating in temperatures from -40‚ºC to +85‚ºC for applications within harsher environments. Concurrent Technologies produces a wide range of boards designed according to industry standard specifications including CompactPCI‚®, VME boards, AdvancedMC¢â€ž¢, PCI Mezzanine Cards and Multibus II.

The TP 402/351-RC uses the 1.5 GHz Intel‚® Core¢â€ž¢ 2 Duo processor with the Intel‚® 3100 server chipset and supports an XMC module in a single slot. It can operate in a system slot, peripheral slot or as a blade. The board operates at altitudes of -1000 to +50,000 feet (-305 to +15,240 metres) over -40‚°C to +85‚°C (no airflow) and the ruggedized version enables it to operate to a shock of 40g (11ms, half-sine), sine vibration 5g (5Hz-2KHz) and random vibration, 0.1g‚²/Hz (10Hz-1KHz) and 6dB/octave from 1KHz to 2KHz.

CONCURRENT TECHNOLOGIES PLC
Date   Source Headline
20th Oct 20209:07 amRNSTreasury Shares
16th Oct 20207:00 amRNSIssue of Share Options and PDMR dealing
16th Oct 20207:00 amRNSTreasury Shares
6th Oct 20204:50 pmRNSTotal Voting Rights
11th Sep 20203:07 pmRNSDirector/PDMR Shareholding
2nd Sep 20207:00 amRNSInterim Results
21st Aug 20207:00 amRNSNotification of Interim Results
23rd Jul 202011:15 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSRetirement of Director
17th Jun 20202:33 pmRNSResult of AGM
16th Jun 20202:45 pmRNSAGM Statement
9th Jun 20205:17 pmRNSTotal Voting Rights & Director Shareholding
1st Jun 20207:00 amRNSHolding(s) in Company
29th May 20207:00 amRNSHolding(s) in Company
27th May 20204:55 pmRNSTotal Voting Rights & Director Shareholding
22nd May 20202:34 pmRNSPosting of Annual Report and Notice of AGM
22nd May 20207:00 amRNSDirector Appointment
12th May 20207:00 amRNSTotal Voting Rights
30th Apr 20206:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSResults for the year ended 31 December 2019
17th Apr 20207:00 amRNSNotice of Results
26th Mar 20207:00 amRNSDirector Appointment and Results Timing Update
10th Mar 20207:00 amRNSSecond Interim Dividend
14th Feb 20206:06 pmRNSDirector/PDMR Shareholding
12th Feb 202012:18 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSProduct Announcement
24th Jan 20204:29 pmRNSHolding(s) in Company
21st Jan 20207:00 amRNSPost-Close Trading Update
7th Jan 20202:13 pmRNSHolding(s) in Company
7th Jan 20202:10 pmRNSHolding(s) in Company
6th Jan 202012:29 pmRNSHolding(s) in Company
20th Nov 201910:14 amRNSHolding(s) in Company
11th Oct 20191:45 pmRNSDirector/PDMR Shareholding
10th Sep 20197:00 amRNSInterim Results
9th Aug 20197:00 amRNSNotice of Interim Results
11th Jun 20198:45 amRNSProduct Announcement
22nd May 20194:41 pmRNSResult of AGM
21st May 20192:30 pmRNSAGM Statement
8th May 20197:00 amRNSDeath of Director
24th Apr 20197:00 amRNSDistribution of Annual Report and Accounts
4th Apr 20197:00 amRNSResults for the year ended 31 December 2018
29th Mar 20197:00 amRNSNotice of Results
14th Mar 20197:00 amRNSSecond Interim Dividend
6th Mar 20197:00 amRNSProduct Announcement
17th Jan 20192:50 pmRNSPost-Close Trading Update
14th Jan 20192:00 pmRNSLeave of Absence
8th Oct 20187:00 amRNSProduct Announcement
12th Sep 20187:00 amRNSInterim Results
6th Sep 20187:00 amRNSNotification of Interim Results
8th Jun 20187:00 amRNSProduct Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.